Update on selected salivary gland neoplasms

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 11, 2009, Pages 1763-1774

  McHugh, Jonathan B ^a   Visscher, Daniel W ^a   Barnes, E Leon ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GRADING; CONFERENCE PAPER; HUMAN; IMMUNOHISTOCHEMISTRY; MYOEPITHELIOMA; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; CARCINOMA IN SITU; CARCINOSARCOMA; HUMANS; SALIVARY DUCTS; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 70449435922     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Ellis GL, Auclair RL. Tumors of the Salivary Glands. Washington, DC: Armed Forces Institute of Pathology; 1996. Atlast of Tumor Pathology; 3rd series.
2. Gnepp DR, Brandwein-Gensler MS, El-Nagger AK, Nagao T. Carcinoma ex pleomorphic adenoma. Barnes EL, Eveson JW, Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumors. Lyon, France: IARC Press; 2005:242-243. World Health Organization Classification of Tumours; vol 9.
3. Seifert G, Langrock I, Donath K. A pathological classification of pleomorphic adenoma of the salivary glands [author's transl; in German]. HNO. 1976;24(12):415-426.
4. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993;28(pt 1):279-328.
5. Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod Pathol. 1996;9(6):652-657.
6. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol. 2001;32(6):596-604. (Pubitemid 32601241)
7. Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumors: histomorphologic indexes. Arch Otolaryngol. 1984;110(3):172-176. (Pubitemid 14197526)
8. Brandwein M, Huvos AG, Dardick I, Thomas MJ, Theise ND. Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(6):655-664. (Pubitemid 126812982)
9. Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck. 2001;23(9):705-712. (Pubitemid 32751485)
10. DeRoche TC, Hoschar AP, Hunt JL. Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas. Arch Pathol Lab Med. 2008;132(12):1907-1911.
11. LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands - I, carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer. 1977;39(5):2209-2230.
12. Felix A, Rosa-Santos J, Mendonca ME, Torrinha F, Soares J. Intracapsular carcinoma ex pleomorphic adenoma: report of a case with unusual metastatic behaviour. Oral Oncol. 2002;38(1):107-110. (Pubitemid 34076580)
13. Freedman PD, Lumerman H. Lobular carcinoma of intraoral minor salivary gland origin: report of twelve cases. Oral Surg Oral Med Oral Pathol. 1983;56(2): 157-166.
14. Batsakis JG, Pinkston GR, Luna MA, Byers RM, Sciubba JJ, Tillery GW. Adenocarcinomas of the oral cavity: a clinicopathologic study of terminal duct carcinomas. J Laryngol Otol. 1983;97(9):825-835.
15. Evans HL, Batsakis JG. Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 14 cases of a distinctive neoplasm. Cancer. 1984;53(4):935-942.
16. Vincent SD, Hammond HL, Finkelstein MW. Clinical and therapeutic features of polymorphous low-grade adenocarcinoma. Oral Surg Oral Med Oral Pathol. 1994;77(3):41-47.
17. Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer. 1999;86(2):207-219. (Pubitemid 29327577)
18. Evans HL, Luna MA. Polymorphous low-grade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas. Am J Surg Pathol. 2000;24(10):1319-1328.
19. Penner CR, Folpe AL, Budnick SD. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol. 2002;15(7):687-691. (Pubitemid 34787302)
20. Edwards PC, Bhuiya T, Kelsch RD. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(5):586-593. (Pubitemid 36886706)
21. Vargas h SD, Kaplan MJ, et al. Mixed tumor, polymorphous low grade adenocarcinoma and adenoid cystic carcinoma of the salivary gland: pathogenic implication and differential diagnosis by Ki-67 (MIB 1), BLC 2 and S-100 immunohistochemistry. Applied Immunohistochemistry. 1997;8:8-16.
22. Skálová A, Simpson RH, Lehtonen H, Leivo I. Assessment of proliferative activity using the MIB1 antibody helps to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Pathol Res Pract. 1997;193(10):695-703. (Pubitemid 28064116)
23. Mills SE, Garland TA, Allen MS Jr. Low-grade papillary adenocarcinoma of palatal salivary gland origin. Am J Surg Pathol. 1984;8(5):367-374.
24. Michal M, Skálová A, Simpson RH, et al. Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology. 1999;35(6):495-501. (Pubitemid 30005375)
25. Kleinsasser O, Klein HJ, Hubner G. Speichelgangcarcinoma: Ein den Milchgangcarcinoma der Brustdruse analoge Gruppe von Speildrusen tumoren [in German]. Arch Kin Exp Ohre Nasen Kehlkopfheilkd. 1968;192(1):100-105.
26. Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD. Salivary duct carcinoma: clinicopathologic and immunohistochemical review of 26 cases. Cancer. 1996;77(2):223-230. (Pubitemid 26023338)
27. Barnes L, Rao U, Krause J, Contis L, Schwartz A, Scalamogna P. Salivary duct carcinoma - part I: a clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature. Oral Surg Oral Med Oral Pathol. 1994;78(1):64-73.
28. Simpson RH, Desai S, Di Palma S. Salivary duct carcinoma in situ of the parotid gland. Histopathology. 2008;53(4):416-425.
29. Henley JD, Seo IS, Dayan D, et al. Sarcomatoid salivary duct carcinoma of the parotid gland. Hum Pathol. 2000;31(2):208-213. (Pubitemid 30090650)
30. Nagao T, Gaffey TA, Visscher DW, et al. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance. Am J Surg Pathol. 2004;28(3):319-326. (Pubitemid 38269565)
31. Simpson RH, Prasad AR, Lewis JE, Skálová A, David L. Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases. Am J Surg Pathol. 2003;27(8):1070-1079. (Pubitemid 36909528)
32. Tse LL, Finkelstein SD, Siegler RW, Barnes L. Osteoclast-type giant cell neoplasm of salivary gland: a microdissection-based comparative genotyping assay and literature review - extraskeletal "giant cell tumor of bone" or osteoclast-type giant cell "carcinoma"? Am J Surg Pathol. 2004;28(7): 953-961.
33. Delgado R, Klimstra D, Albores-Saavedra J. Low grade salivary duct carcinoma: a distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer. 1996;78(5):958-967. (Pubitemid 26284859)
34. Dimery IW, Jones LA, Verjan RP, Raymond AK, Goepfert H, Hong WK. Estrogen receptors in normal salivary gland and salivary gland carcinoma. Arch Otolaryngol Head Neck Surg. 1987;113(10):1082-1085. (Pubitemid 18058225)
35. Delgado R, Vuitch F, Albores-Saavedra J. Salivary duct carcinoma. Cancer. 1993;72(5):1503-1512.
36. Barnes L, Rao U, Contis L, Krause J, Schwartz A, Scalamogna P. Salivary duct carcinoma - part II: immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein. Oral Surg Oral Med Oral Pathol. 1994;78(1):74-80.
37. Kay PA, Roche PC, Olsen KD. Salivary duct carcinoma: immunohistochemical analysis of androgen receptor, prostatic markers and HER-2/Neu oncoprotein in 40 cases. Lab Invest. 2001;81:140A.
38. Ockner DM, Mills SE, Swanson PE, et al. Salivary duct carcinoma: an immunohistologic comparison with invasive ducal carcinoma of the breast. Lab Invest. 1994;70:100A.
39. Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors: frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003; 119(6):801-806. (Pubitemid 37047840)
40. Hoang MP, Callender DL, Sola Gallego JJ, et al. Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. Int J Oncol. 2001;19(4):865-871.
41. Kapadia SB, Barnes L. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol. 1998; 11(11):1033-1038. (Pubitemid 28525007)
42. Skálová A, Stárek I, Vanecek T, et al. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology. 2003;42(4): 348-356. (Pubitemid 36459812)
43. Cornolti G, Ungari M, Morassi ML, et al. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland. Arch Otolaryngol Head Neck Surg. 2007;133(10):1031-1036. (Pubitemid 47607587)
44. Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy. Head Neck. 2007;29(10):907-912.
45. Johnson CJ, Barry MB, Vasef MA, Deyoung BR. Her-2/neu expression in salivary duct carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Appl Immunohistochem Mol Morphol. 2008;16(1):54-58.
46. Fan CY, Wang J, Barnes EL. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol. 2000;24(4):579-586. (Pubitemid 30180753)
47. Williams MD, Roberts D, Blumenschein GR Jr, et al. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol. 2007;31(11):1645-1652. (Pubitemid 350287562)
48. Gnepp DR. Metastatic disease to the major salivary gland. In: Ellis, GL, Auclair PL, Gnepp DR, eds. Surgical Pathology of the Salivary Glands. Philadelphia, PA: WB Saunders; 1991:560-569.
49. Alos L, Cardesa A, Bombi JA, et al. Myoepithelial tumors of salivary glands: a clinicopathologic, immunohistochemical, ultrastructural, and flow-cytometric study. Semin Diagn Pathol. 1996;13(2):138-147. (Pubitemid 26149597)
50. Barnes L, Appel BN, Perez H, El-Attar AM. Myoepithelioma of the head and neck: case report and review. J Surg Oncol. 1985;28(1):21-28. (Pubitemid 15169289)
51. Savera AT, Sloman A, Huvos AG, Klimstra DS. Myoepithelial caricnoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol. 2000;24(6):761-774. (Pubitemid 30366263)
52. Nagao T, Sugano I, Ishida Y, et al. Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of ten cases. Cancer. 1998;83(7):1292-1299. (Pubitemid 28460078)
53. McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR. p63 immunohistochemistry differentiates salivary glands oncocytoma and ococytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol. 2007;1(2):123-131.